Hematopoietic Stem Cell Transplant for Sickle Cell Disease: PATIENT SELEction and Timing Based on Sickle Cell-Related Multiple Chronic Conditions

Hematopoietic stem cell transplant (HSCT) is the only cure for patients with sickle cell disease (SCD). Although most SCD patients experience progressive end-organ damage and shortened lifespans, not all patients follow the same disease course, tempo, or outcome. Therefore, the dilemma facing physic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Tim, Mo, George, Stewart, Connor, Khoury, Leen, Ferguson, Natalie, Egini, Ogechukwu, Muthu, John, Dutta, Dibyendu, Salifu, Moro, Lim, Seah H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504222/
https://www.ncbi.nlm.nih.gov/pubmed/34628962
http://dx.doi.org/10.1177/09636897211046559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504222/
https://www.ncbi.nlm.nih.gov/pubmed/34628962
http://dx.doi.org/10.1177/09636897211046559

Ejemplares similares